Špičkoví odborníci na diabetes a spoločnosť AI smerujúca do Guamu

GMRC will be joined by Dr. Erika Alford, who will serve as the local Principal Investigator of the study. Dr. Alford is an Endocrinologist with American Medical Center, and brings ten years of experience caring for patients with diabetes on Guam and her deep understanding of the nuances of diabetes care on the island.

“The prevalence of diabetes in Guam is extremely high. Every day, we care for numerous patients not only with diabetes, but also with complications associated with diabetes. Improving diabetes care is a crucial step towards preventing these long-term complications associated with diabetes,” said Dr. Hoa V. Nguyen, founding member of AMC.   

Calvo’s SelectCare will provide historical claims data to assist with the study, as well as recruiting participants for the prospective section of the Validation Study in 2022.

Frank J. Campillo, Health Plan Administrator for Calvo’s SelectCare, said, “This diabetes study will be groundbreaking for our resident population, as it may help the future medical management and coordination of care for the diabetic population.  As part of our quality initiatives, we continue supporting innovative and more effective methods of care for our members, and this study can provide results that directly impact their overall health and well-being. We embrace this new frontier in medical research.  We are confident that the important data collected through this study will provide our medical community with valuable insights to potentially improve the quality of care for diabetic patients locally and around the world.”

“Today we benefit from advanced AI analytics in many areas of our lives, including online shopping, autonomous transportation, voice recognition, and entertainment choices.  Why shouldn’t we be able to do the same in healthcare, especially for someone with a chronic illness to help them stay healthy?” continued Dr. Klonoff.  “We hope that by partnering here on Guam, we will be able to showcase the power of assembling this data on behalf of patient care.”

AI zdravie specializes in using AI and IoT to provide simple healthcare solutions that work in real world today, in a cost effective, privacy compliant manner, and provide a foundation for the future of Predictive Analytics in Healthcare and Remote Patient Monitoring. The company is based in San Francisco with an AI Lab in Barcelona, Spain.